Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sato, N.
Right arrow Articles by Koike, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sato, N.
Right arrow Articles by Koike, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

In vitro expansion of human peripheral blood CD34+ cells

N Sato, K Sawada, K Koizumi, T Tarumi, M Ieko, T Yasukouchi, M Yamaguchi, TA Takahashi, S Sekiguchi and T Koike

Department of Internal Medicine II, Hokkaido University School of Medicine, Japan.

To elucidate the role of recombinant human colony-stimulating factors (CSFs) for expanding peripheral blood (PB) CD34+ cells, these cells were purified up to 94.5% +/- 1.3% and the effects of individual and combined CSFs on the proliferation and differentiation of these cells were studied in a 7-day suspension culture. The majority of CD34+ cells coexpressed CD38 (81.8% +/- 5.1%), but was negative for CD33 (88.5% +/- 3.4%). Among the individual CSFs examined, recombinant interleukin-3 (rIL-3) was identified as the most potent factor for expanding PB progenitor cells and increased nonerythroid progenitor cells 13- +/- 4- fold (P < .01). Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF), recombinant granulocyte-CSF (rG-CSF), recombinant macrophage-CSF (rM-CSF), rIL-6, rIL-11, and recombinant stem cell factor (rSCF) did not alone expand nonerythroid progenitor cells. A combination of 5 CSFs, ie, rIL-3, rIL-6, rGM-CSF, rG-CSF, and rSCF, was identified as the most potent combination of those tested and increased nonerythroid progenitor cells 57- +/- 11-fold. After a 7-day suspension culture of CD34+ cells with these 5 CSFs, CD34+ cells expanded 14.5- fold, and CD34+/CD33- cells and CD34+/CD33+ cells were also expanded 2.9-fold and 307-fold, respectively. Most secondary colonies derived from expanded cells were small; however, the absolute number of large- sized colonies expanded 5.9- +/- 3.3-fold. Thus, the combination of CSFs can achieve a degree of amplification of PB CD34+ cells. The capability of in vitro expansion of PB CD34+ cells as an adjunct to PB stem cell transplantation is worthy of consideration.

Volume 82, Issue 12, pp. 3600-3609, 12/15/1993
Copyright © 1993 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Stem CellsHome page
L. Kobari, M. C. Giarratana, J. C. Gluckman, L. Douay, and M. Rosenzwajg
Ex Vivo Expansion Does Not Alter the Capacity of Umbilical Cord Blood CD34+ Cells to Generate Functional T Lymphocytes and Dendritic Cells
Stem Cells, September 1, 2006; 24(9): 2150 - 2157.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. P. Chute, G. G. Muramoto, J. Fung, and C. Oxford
Soluble factors elaborated by human brain endothelial cells induce the concomitant expansion of purified human BM CD34+CD38- cells and SCID-repopulating cells
Blood, January 15, 2005; 105(2): 576 - 583.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Gur, R. Krauthgamer, A. Berrebi, T. Klein, A. Nagler, A. Tabilio, M. F. Martelli, and Y. Reisner
Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34+ cells
Blood, May 13, 2002; 99(11): 4174 - 4181.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
R. Huss
Isolation of Primary and Immortalized CD34- Hematopoietic and Mesenchymal Stem Cells from Various Sources
Stem Cells, January 1, 2000; 18(1): 1 - 9.
[Abstract] [Full Text]


Home page
BloodHome page
T. Matsunaga, F. Hirayama, Y. Yonemura, R. Murray, and M. Ogawa
Negative Regulation by Interleukin-3 (IL-3) of Mouse Early B-Cell Progenitors and Stem Cells in Culture: Transduction of the Negative Signals by beta c and beta IL-3 Proteins of IL-3 Receptor and Absence of Negative Regulation by Granulocyte-Macrophage Colony-Stimulating Factor
Blood, August 1, 1998; 92(3): 901 - 907.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. C. Broudy
Stem Cell Factor and Hematopoiesis
Blood, August 15, 1997; 90(4): 1345 - 1364.
[Full Text] [PDF]


Home page
BloodHome page
X. Du and D. A. Williams
Interleukin-11: Review of Molecular, Cell Biology, and Clinical Use
Blood, June 1, 1997; 89(11): 3897 - 3908.
[Full Text] [PDF]


Home page
BloodHome page
F. Prosper, K. Vanoverbeke, D. Stroncek, and C. M. Verfaillie
Primitive Long-Term Culture Initiating Cells (LTC-ICs) in Granulocyte Colony-Stimulating Factor Mobilized Peripheral Blood Progenitor Cells Have Similar Potential for Ex Vivo Expansion as Primitive LTC-ICs in Steady State Bone Marrow
Blood, June 1, 1997; 89(11): 3991 - 3997.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
J. A. LaIuppa, E. T. Papoutsakis, and W. M. Miller
Evaluation of Cytokines for Expansion of the Megakaryocyte and Granulocyte Lineages
Stem Cells, May 1, 1997; 15(3): 198 - 206.
[Abstract] [Full Text]


Home page
BloodHome page
Y. Yonemura, H. Ku, S. D. Lyman, and M. Ogawa
In Vitro Expansion of Hematopoietic Progenitors and Maintenance of Stem Cells: Comparison Between FLT3/FLK-2 Ligand and KIT Ligand
Blood, March 15, 1997; 89(6): 1915 - 1921.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. Aiuti, I.J. Webb, C. Bleul, T. Springer, and J.C. Gutierrez-Ramos
The Chemokine SDF-1 Is a Chemoattractant for Human CD34+ Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34+ Progenitors to Peripheral Blood
J. Exp. Med., January 1, 1997; 185(1): 111 - 120.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
H. Sakabe, Y. Ohmizono, S. Tanimukai, T. Kimura, K. J. Morie, T. Abe, and Y. Sonoda
Functional Differences between Subpopulations of Mobilized Peripheral Blood-Derived CD34+ Cells Expressing Different Levels of HLA-DR, CD33, CD38 and c-kit Antigens
Stem Cells, January 1, 1997; 15(1): 73 - 81.
[Abstract] [Full Text]


Home page
Stem CellsHome page
I. Ayala, A Tomer, and K. Kellar
Flow cytometric analysis of megakaryocyte-associated antigens on CD34 cells and their progeny in liquid culture
Stem Cells, May 1, 1996; 14(3): 320 - 329.
[Abstract]


Home page
ScienceHome page
A. Berardi, A Wang, J. Levine, P Lopez, and D. Scadden
Functional isolation and characterization of human hematopoietic stem cells
Science, January 6, 1995; 267(5194): 104 - 108.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
T Mahdi, A Brizard, C Millet, P Dore, J Tanzer, and A Kitzis
In vitro p53 and/or Rb antisense oligonucleotide treatment in association with growth factors induces the proliferation of peripheral hematopoietic progenitors
J. Cell Sci., January 3, 1995; 108(3): 1287 - 1293.
[Abstract] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1993 by American Society of Hematology         Online ISSN: 1528-0020